|
注册号: Registration number: |
ChiCTR-IOR-17011994 |
|
最近更新日期: Date of Last Refreshed on: |
2021-11-30 05:07:35 |
|
注册时间: Date of Registration: |
2017-07-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
口服碳水化合物补充剂对硬膜外分娩镇痛产妇剖宫产几率的影响 |
|
Public title: |
Effect of oral carbohydrate drink on rate of cesarean delivery in parturients with epidural labor analgesia |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
口服碳水化合物补充剂对硬膜外分娩镇痛产妇剖宫产几率的影响:多中心随机开放式研究 |
|
Scientific title: |
Effect of oral carbohydrate drink on rate of cesarean delivery in parturients with epidural labor analgesia: a multicenter randomized trial |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
丁婷 |
研究负责人: |
曲元 |
|
Applicant: |
Ding Ting |
Study leader: |
Qu Yuan |
|
申请注册联系人电话: Applicant telephone: |
+86 10 83573218 |
研究负责人电话:
Study leader's |
+86 10 83573218 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
athena_d@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
quyuanbj@hotmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市西城区西安门大街1号 |
研究负责人通讯地址: |
北京市西城区西安门大街1号 |
|
Applicant address: |
1 Xi'anmen Street, Xicheng District, Beijing, China |
Study leader's address: |
1 Xi'anmen Street, Xicheng District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京大学第一院医院麻醉科 |
||
|
Applicant's institution: |
Anesthesiology Department of Peking University First Hospital |
||
|
研究负责人所在单位: |
北京大学第一院医院麻醉科 |
||
|
Affiliation of the Leader: |
Anesthesiology Department of Peking University First Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2017[1360] |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学第一医院临床研究伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Peking University First Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2017-06-09 00:00:00 | ||
|
伦理委员会联系人: |
于荣辉 |
||
|
Contact Name of the ethic committee: |
Yu Ronghui |
||
|
伦理委员会联系地址: |
北京市西城区西安门大街1号 |
||
|
Contact Address of the ethic committee: |
1 Xi'anmen Street, Xicheng District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
北京大学第一医院 麻醉科 |
||||||||||||||||||||||
|
Primary sponsor: |
Anesthesiology Department of Peking University First Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市西城区西安门大街1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Xi'anmen Street, Xicheng District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-finance |
||||||||||||||||||||||
|
研究疾病: |
剖宫产几率 |
||||||||||||||||||||||
|
Target disease: |
rate of cesarean delivery |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
上市后药物 | ||||||||||||||||||||||
|
Study phase: |
4 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本多中心研究的主要目的在于进行口服碳水化合物饮料和清亮液体对与接受了硬膜外分娩镇痛产妇剖宫产几率的影响比较。 同时对其他母婴结局(如产程时长,产钳使用几率,母婴产后血糖等)进行研究。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this multicenter trial was to compare the impact of carbohydrate drink versus clear liquid drink on the incidence of cesarean delivery in laboring women with epidural analgesia. And other maternal-fetal outcomes (duration of labor, incidence of forceps delivery, maternal-neonatal blood glucose after delivery, etc.) |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
口服碳水化合物补充剂 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
carbohydrate drink |
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 年龄<18岁或者>34岁; |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Aged < 18 or > 34 years. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2017-08-01 00:00:00至 To 2019-07-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2017-08-01 00:00:00 至 To 2018-07-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
SAS统计软件包 (SAS 9.2, SAS Institute Inc. USA, North Carolina) |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
SAS statistical package (SAS 9.2, SAS Institute Inc. USA, North Carolina) |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
开放(产后评估者盲) |
|
Blinding: |
open-label(outcome assessor blind) |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
北京大学第一医院 请阅读网页注册指南中关于 原始数据共享 的内容。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Peking University First Hospital |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF表记录,EDC管理,REDCap数据库 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF EDC REDCap database |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |